Table 4.

The association of macular vascular variables at baseline with the intractable nature of macular lesions.

	Improved	Refractory	P-value
Vascular density (%)
SCP	47.69 ± 4.41	42.73 ± 4.36	0.009*
DCP	47.60 ± 6.69	40.39 ± 6.29	0.010*
Fractal dimension
SCP	1.62 ± 0.05	1.60 ± 0.05	0.629*
DCP	1.62 ± 0.06	1.61 ± 0.07	0.604*
Treatment			0.763‡
LP	5 (45.4%)	5 (33.3%)	/
LP + IVR	3 (27.3%)	4 (26.7%)	/
Combined PPV	3 (27.3%)	6 (40.0%)	/
AL, mm	22.63 ± 0.86	22.51 ± 0.83	0.740

SCP, superficial capillary plexus; DCP, deep capillary plexus; LP, laser photocoagulation; IVR, intravitreal injection of Ranibizumab; PPV, pars-plana vitrectomy; AL, axial length.

Statistics:

^*Unpaired t-test.

^‡Fisher's exact test. Values in bold font are statistically significant at P < 0.05.